Xueshuantong injection alleviates ischemic heart failure via targeting PFKP-mediated endothelial-to-mesenchymal transition
- 14 March 2026
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 155, 158085
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Guangxi Province (2022GXNSFDA080001)
- Guangdong Provincial Key Laboratory of Construction Foundation
- National Natural Science Foundation of China (82473915)
- National Natural Science Foundation of China (82273925)
- Basic and Applied Basic Research Foundation of Guangdong Province (2025A1515011819)
This publication has 31 references indexed in Scilit:
- Non-targeted metabolomic analysis of Xueshuantong injection in patients with STEMIFitoterapia, 2025
- Potential Candidates of Natural Antioxidants From Herbs for Treating Lung Disorders: Focus on Redox Balance and Natural ProductsPhytotherapy Research, 2025
- Panax notoginseng saponins promotes angiogenesis after cerebral ischemia-reperfusion injuryJournal of Ginseng Research, 2024
- Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunctionAngiogenesis, 2024
- Nur77 deficiency exacerbates cardiac fibrosis after myocardial infarction by promoting endothelial‐to‐mesenchymal transitionJournal of Cellular Physiology, 2020
- PFKP is highly expressed in lung cancer and regulates glucose metabolismCellular Oncology, 2020
- Panax notoginseng saponins administration modulates pro- /anti-inflammatory factor expression and improves neurologic outcome following permanent MCAO in ratsMetabolic Brain Disease, 2016
- Aortic Pulse Wave Velocity Improves Cardiovascular Event PredictionJACC, 2014
- Fibrosis and heart failureHeart Failure Reviews, 2012
- Prediction of Cardiovascular Events and All-Cause Mortality With Arterial StiffnessJACC, 2010